Andreas Toft Sørensen

Medicine & Life Sciences

1. Action Potentials 34%
2. Attention Deficit Disorder with Hyperactivity 15%
3. Brain 24%
4. Cell- and Tissue-Based Therapy 18%
5. Channelrhodopsins 17%
6. Chlorides 22%
7. Designer Drugs 49%
8. Dopamine 50%
9. Dopaminergic Neurons 69%
10. Epilepsy 53%
11. Galanin 28%
12. Genes 28%
13. Genetic Therapy 22%
14. Glutamic Acid 16%
15. Halorhodopsins 20%
16. Hippocampus 75%
17. In Vitro Techniques 19%
18. Induced Pluripotent Stem Cells 15%
19. Interneurons 19%
20. Learning 21%
21. Light 20%
22. Long-Term Potentiation 19%
23. Memory 19%
24. Mesencephalon 17%
25. Microbial Rhodopsins 24%
26. Natronomonas 26%
27. Neural Stem Cells 29%
28. Neuroepithelial Cells 16%
29. Neuronal Plasticity 31%
30. Neurons 80%
31. Neuropeptide Y 100%
32. neuropeptide Y C-terminal flanking peptide 27%
33. Neuropeptide Y Receptors 66%
34. neuropeptide Y2 receptor 29%
35. Neuropeptides 19%
36. Optogenetics 98%
37. Parkinson Disease 16%
38. preproneuropeptide Y 25%
39. Psychological Inhibition 29%
40. Psychology Transfer 31%
41. Seizures 83%
42. Stem Cells 32%
43. Synapses 49%
44. Synaptic Transmission 25%
45. Temporal Lobe Epilepsy 15%
46. Transgenes 24%
47. Transplants 20%
48. Ventral Tegmental Area 28%